Johnson & Johnson financial data

Symbol
JNJ on NYSE
Industry
Pharmaceutical Preparations
Location
One Johnson & Johnson Plz, New Brunswick, New Jersey
State of incorporation
New Jersey
Fiscal year end
December 29
Former names
JOHNSON & JOHNSON ET AL (to 1/23/1996)
Latest financial report
10-Q - Q2 2024 - Jul 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 115 % +1%
Quick Ratio 23.8 % +7.66%
Debt-to-equity 144 %
Return On Equity 54 % +209%
Return On Assets 22.2 % +218%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.41B shares -7.38%
Entity Public Float 430B USD -8.9%
Common Stock, Value, Issued 3.12B USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.41B shares -7.37%
Weighted Average Number of Shares Outstanding, Diluted 2.42B shares -7.76%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 86.6B USD +5.13%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 19.5B USD +39%
Income Tax Expense (Benefit) 3.12B USD +126%
Net Income (Loss) Attributable to Parent 38B USD +191%
Earnings Per Share, Basic 15.3 USD/shares +206%
Earnings Per Share, Diluted 15.2 USD/shares +207%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.9B USD +17.4%
Marketable Securities, Current 597M USD -91.8%
Cash, Cash Equivalents, and Short-term Investments 25.5B USD -10.7%
Accounts Receivable, after Allowance for Credit Loss, Current 15.8B USD -5.86%
Inventory, Net 12.2B USD -5.58%
Assets, Current 57.8B USD -4.54%
Deferred Income Tax Assets, Net 9B USD +2.56%
Property, Plant and Equipment, Net 19.7B USD -4.02%
Operating Lease, Right-of-Use Asset 1B USD -9.09%
Intangible Assets, Net (Excluding Goodwill) 39.7B USD -14.1%
Goodwill 44.3B USD -2.62%
Other Assets, Noncurrent 10.5B USD +4.62%
Assets 181B USD -5.53%
Accounts Payable, Current 8.85B USD -15.3%
Employee-related Liabilities, Current 2.84B USD -7.15%
Accrued Liabilities, Current 10.5B USD -0.62%
Liabilities, Current 53.9B USD -0.44%
Accrued Income Taxes, Noncurrent 341M USD -86.6%
Deferred Income Tax Liabilities, Net 2.64B USD -27.4%
Other Liabilities, Noncurrent 14.1B USD -3.4%
Liabilities 110B USD -4.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11.3B USD +14.3%
Retained Earnings (Accumulated Deficit) 155B USD +20.1%
Stockholders' Equity Attributable to Parent 71.5B USD -4.81%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 71.5B USD -6.38%
Liabilities and Equity 181B USD -5.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.66B USD +12.3%
Net Cash Provided by (Used in) Financing Activities 546M USD -91.1%
Net Cash Provided by (Used in) Investing Activities -464M USD -114%
Common Stock, Shares Authorized 4.32B shares 0%
Common Stock, Shares, Issued 3.12B shares 0%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.61B USD -71.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.9B USD +17.4%
Operating Lease, Liability 1.1B USD -15.4%
Payments to Acquire Property, Plant, and Equipment 807M USD -6.49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.2B USD +2.79%
Property, Plant and Equipment, Gross 48B USD -6.22%
Deferred Income Tax Expense (Benefit) -1.56B USD -1.23%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 2.5B USD +400%
Amortization of Intangible Assets 4.5B USD +15.4%
Depreciation, Depletion and Amortization 1.82B USD -3.46%
Deferred Tax Assets, Net of Valuation Allowance 12.7B USD -1.29%
Interest Expense 715M USD +49.6%